• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类 Na1.3 受临床药物和选择性拮抗剂调节的结构基础。

Structural basis for modulation of human Na1.3 by clinical drug and selective antagonist.

机构信息

Laboratory of Soft Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, 100190, China.

National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

出版信息

Nat Commun. 2022 Mar 11;13(1):1286. doi: 10.1038/s41467-022-28808-5.

DOI:10.1038/s41467-022-28808-5
PMID:35277491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8917200/
Abstract

Voltage-gated sodium (Na) channels play fundamental roles in initiating and propagating action potentials. Na1.3 is involved in numerous physiological processes including neuronal development, hormone secretion and pain perception. Here we report structures of human Na1.3/β1/β2 in complex with clinically-used drug bulleyaconitine A and selective antagonist ICA121431. Bulleyaconitine A is located around domain I-II fenestration, providing the detailed view of the site-2 neurotoxin binding site. It partially blocks ion path and expands the pore-lining helices, elucidating how the bulleyaconitine A reduces peak amplitude but improves channel open probability. In contrast, ICA121431 preferentially binds to activated domain IV voltage-sensor, consequently strengthens the Ile-Phe-Met motif binding to its receptor site, stabilizes the channel in inactivated state, revealing an allosterically inhibitory mechanism of Na channels. Our results provide structural details of distinct small-molecular modulators binding sites, elucidate molecular mechanisms of their action on Na channels and pave a way for subtype-selective therapeutic development.

摘要

电压门控钠离子 (Na) 通道在启动和传播动作电位方面发挥着重要作用。Na1.3 参与了许多生理过程,包括神经元发育、激素分泌和疼痛感知。在这里,我们报告了与人 Na1.3/β1/β2 复合物的结构,该复合物与临床使用的药物乌头碱 A 和选择性拮抗剂 ICA121431 结合。乌头碱 A 位于 I 型-II 型窗孔周围,提供了位点 2 神经毒素结合位点的详细视图。它部分阻断离子通道,并扩展了孔衬螺旋,阐明了乌头碱 A 如何降低峰值幅度但提高通道开放概率。相比之下,ICA121431 优先结合激活的 IV 型电压传感器,从而加强了 Ile-Phe-Met 基序与其受体位点的结合,使通道稳定在失活状态,揭示了 Na 通道的变构抑制机制。我们的研究结果提供了不同小分子调节剂结合位点的结构细节,阐明了它们在 Na 通道上的作用的分子机制,并为亚型选择性治疗的发展铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/5c8cb975fc48/41467_2022_28808_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/e2cf6156fb78/41467_2022_28808_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/dc9d4b2bf928/41467_2022_28808_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/9a0402197d27/41467_2022_28808_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/7a91ada2d70e/41467_2022_28808_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/5c8cb975fc48/41467_2022_28808_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/e2cf6156fb78/41467_2022_28808_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/dc9d4b2bf928/41467_2022_28808_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/9a0402197d27/41467_2022_28808_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/7a91ada2d70e/41467_2022_28808_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376d/8917200/5c8cb975fc48/41467_2022_28808_Fig5_HTML.jpg

相似文献

1
Structural basis for modulation of human Na1.3 by clinical drug and selective antagonist.人类 Na1.3 受临床药物和选择性拮抗剂调节的结构基础。
Nat Commun. 2022 Mar 11;13(1):1286. doi: 10.1038/s41467-022-28808-5.
2
Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.靶向电压门控钠通道Nav1.7的选择性配体与药物发现
Handb Exp Pharmacol. 2018;246:271-306. doi: 10.1007/164_2018_97.
3
Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.电压门控钠离子通道选择性小分子抑制剂的电压传感器相互作用位点。
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):E2724-32. doi: 10.1073/pnas.1220844110. Epub 2013 Jul 1.
4
Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana.从中华婪步甲蜘蛛 Ornithoctonus hainana 中分离出的神经元河豚毒素敏感型电压门控钠通道选择性拮抗剂 hainantoxin-III 的结构与功能。
J Biol Chem. 2013 Jul 12;288(28):20392-403. doi: 10.1074/jbc.M112.426627. Epub 2013 May 23.
5
Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist.Nav1.7 亚型选择性小分子拮抗剂的结构抑制基础。
Science. 2015 Dec 18;350(6267):aac5464. doi: 10.1126/science.aac5464.
6
Backbone resonance assignments of complexes of apo human calmodulin bound to IQ motif peptides of voltage-dependent sodium channels Na1.1, Na1.4 and Na1.7.脱辅基人类钙调蛋白与电压依赖性钠通道Na1.1、Na1.4和Na1.7的IQ模体肽结合的复合物的主链共振归属
Biomol NMR Assign. 2018 Oct;12(2):283-289. doi: 10.1007/s12104-018-9824-5. Epub 2018 May 4.
7
Structural basis for high-voltage activation and subtype-specific inhibition of human Na1.8.人类钠离子通道 Na1.8 高电压激活和亚型特异性抑制的结构基础。
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2208211119. doi: 10.1073/pnas.2208211119. Epub 2022 Jul 19.
8
Bulleyaconitine A attenuates hyperexcitability of dorsal root ganglion neurons induced by spared nerve injury: The role of preferably blocking Nav1.7 and Nav1.3 channels.草乌甲素 A 减轻 spared nerve injury 诱导的背根神经节神经元过度兴奋:优选阻断 Nav1.7 和 Nav1.3 通道的作用。
Mol Pain. 2018 Jan-Dec;14:1744806918778491. doi: 10.1177/1744806918778491.
9
Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency.一箭双雕:靶向电压门控钠离子通道两个结合位点的双价配体可减缓配体解离并增强效力。
J Med Chem. 2020 Nov 12;63(21):12773-12785. doi: 10.1021/acs.jmedchem.0c01107. Epub 2020 Oct 20.
10
Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin.Nav1.7 通道调制型蜘蛛毒素抑制的结构基础。
Cell. 2019 Feb 7;176(4):702-715.e14. doi: 10.1016/j.cell.2018.12.018. Epub 2019 Jan 17.

引用本文的文献

1
The Chemistry and Biology of the Tetrodotoxin Natural Product Family.河豚毒素天然产物家族的化学与生物学
Angew Chem Int Ed Engl. 2025 Aug 25;64(35):e202502404. doi: 10.1002/anie.202502404. Epub 2025 Aug 1.
2
Beyond single targets: leveraging degeneracy in sodium channels for osteoarthritis analgesia.超越单一靶点:利用钠通道的简并性实现骨关节炎镇痛
Pain Rep. 2025 May 27;10(4):e1289. doi: 10.1097/PR9.0000000000001289. eCollection 2025 Aug.
3
The α/β3 complex of human voltage-gated sodium channel hNa1.7 to study mechanistic differences in presence and absence of auxiliary subunit β3.

本文引用的文献

1
Open-state structure and pore gating mechanism of the cardiac sodium channel.心脏钠离子通道的开放态结构和孔道门控机制。
Cell. 2021 Sep 30;184(20):5151-5162.e11. doi: 10.1016/j.cell.2021.08.021. Epub 2021 Sep 13.
2
Structural Basis for Pore Blockade of the Human Cardiac Sodium Channel Na 1.5 by the Antiarrhythmic Drug Quinidine*.抗心律失常药物奎尼丁*阻塞人心房钠通道 Na 1.5 的孔道结构基础。
Angew Chem Int Ed Engl. 2021 May 10;60(20):11474-11480. doi: 10.1002/anie.202102196. Epub 2021 Apr 6.
3
Structural basis for voltage-sensor trapping of the cardiac sodium channel by a deathstalker scorpion toxin.
用于研究辅助亚基β3存在与不存在时机制差异的人类电压门控钠通道hNa1.7的α/β3复合物
J Mol Model. 2025 May 21;31(6):168. doi: 10.1007/s00894-025-06378-9.
4
A High-Throughput Biosensing Approach for Rapid Screening of Compounds Targeting the hNav1.1 Channel: Marine Toxins as a Case Study.一种用于快速筛选靶向hNav1.1通道化合物的高通量生物传感方法:以海洋毒素为例
Mar Drugs. 2025 Mar 9;23(3):119. doi: 10.3390/md23030119.
5
Discovery of Novel Na1.7-Selective Inhibitors with the 1-Indole-3-Propionamide Scaffold for Effective Pain Relief.发现具有1-吲哚-3-丙酰胺骨架的新型Na1.7选择性抑制剂以实现有效止痛
Research (Wash D C). 2025 Jan 29;8:0599. doi: 10.34133/research.0599. eCollection 2025.
6
The differential impacts of equivalent gating-charge mutations in voltage-gated sodium channels.电压门控钠通道中等效门控电荷突变的差异影响。
J Gen Physiol. 2025 Mar 3;157(2). doi: 10.1085/jgp.202413669. Epub 2025 Jan 17.
7
Small molecule inhibits KCNQ channels with a non-blocking mechanism.小分子通过非阻断机制抑制钾电压门控通道亚家族KQT成员通道。
Nat Chem Biol. 2025 Jan 15. doi: 10.1038/s41589-024-01834-8.
8
Drugs exhibit diverse binding modes and access routes in the Nav1.5 cardiac sodium channel pore.药物在Nav1.5心脏钠通道孔中呈现出多样的结合模式和进入途径。
J Gen Physiol. 2025 Mar 3;157(2). doi: 10.1085/jgp.202413658. Epub 2025 Jan 7.
9
Isoform-specific N-linked glycosylation of NaV channel α-subunits alters β-subunit binding sites.钠通道α亚基的亚型特异性N-糖基化改变β亚基结合位点。
J Gen Physiol. 2025 Jan 6;157(1). doi: 10.1085/jgp.202413609. Epub 2024 Dec 16.
10
ELUCIDATING THE DIFFERENTIAL IMPACTS OF EQUIVALENT GATING-CHARGE MUTATIONS IN VOLTAGE-GATED SODIUM CHANNELS.阐明电压门控钠通道中等效门控电荷突变的差异影响。
bioRxiv. 2024 Sep 10:2024.09.09.612021. doi: 10.1101/2024.09.09.612021.
结构基础电压传感器陷阱的心脏钠离子通道的死亡射手蝎毒素。
Nat Commun. 2021 Jan 4;12(1):128. doi: 10.1038/s41467-020-20078-3.
4
Structural Basis for High-Affinity Trapping of the Na1.7 Channel in Its Resting State by Tarantula Toxin.蜘蛛毒素以高亲和力将钠离子通道 1.7 亚型捕获于静息状态的结构基础
Mol Cell. 2021 Jan 7;81(1):38-48.e4. doi: 10.1016/j.molcel.2020.10.039. Epub 2020 Nov 23.
5
Structure of the Cardiac Sodium Channel.心脏钠离子通道的结构。
Cell. 2020 Jan 9;180(1):122-134.e10. doi: 10.1016/j.cell.2019.11.041. Epub 2019 Dec 19.
6
Resting-State Structure and Gating Mechanism of a Voltage-Gated Sodium Channel.静息态电压门控钠离子通道的结构和门控机制。
Cell. 2019 Aug 8;178(4):993-1003.e12. doi: 10.1016/j.cell.2019.06.031. Epub 2019 Jul 25.
7
Structures of human Na1.7 channel in complex with auxiliary subunits and animal toxins.人源 Na1.7 通道与辅助亚基和动物毒素复合物的结构。
Science. 2019 Mar 22;363(6433):1303-1308. doi: 10.1126/science.aaw2493. Epub 2019 Feb 14.
8
Molecular basis for pore blockade of human Na channel Na1.2 by the μ-conotoxin KIIIA.μ-芋螺毒素 KIIIA 阻塞人 Na 通道 Na1.2 的分子基础。
Science. 2019 Mar 22;363(6433):1309-1313. doi: 10.1126/science.aaw2999. Epub 2019 Feb 14.
9
Sodium Channel SCN3A (Na1.3) Regulation of Human Cerebral Cortical Folding and Oral Motor Development.钠离子通道 SCN3A(Na1.3)对人脑皮层折叠和口腔运动发育的调控作用。
Neuron. 2018 Sep 5;99(5):905-913.e7. doi: 10.1016/j.neuron.2018.07.052. Epub 2018 Aug 23.
10
Mutations in SCN3A cause early infantile epileptic encephalopathy.SCN3A 基因突变可导致早发性婴儿癫痫性脑病。
Ann Neurol. 2018 Apr;83(4):703-717. doi: 10.1002/ana.25188. Epub 2018 Mar 30.